Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 226

1.

Corrigendum: quality indicators for ERCP.

Adler DG, Lieb JG, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S.

Am J Gastroenterol. 2015 Apr;110(4):608. doi: 10.1038/ajg.2015.75. No abstract available.

PMID:
25853209
2.

Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett's esophagus: results from the U.S. RFA Registry.

Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ.

Gastrointest Endosc. 2015 Apr 1. pii: S0016-5107(15)00017-6. doi: 10.1016/j.gie.2015.01.015. [Epub ahead of print]

PMID:
25841575
3.

Recurrent intestinal metaplasia after radiofrequency ablation for Barrett's esophagus: endoscopic findings and anatomic location.

Cotton CC, Wolf WA, Pasricha S, Li N, Madanick RD, Spacek MB, Ferrell K, Dellon ES, Shaheen NJ.

Gastrointest Endosc. 2015 Mar 24. pii: S0016-5107(14)02599-1. doi: 10.1016/j.gie.2014.12.029. [Epub ahead of print]

PMID:
25817897
4.

Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.

Dellon ES, Rusin S, Gebhart JH, Covey S, Higgins LL, Beitia R, Speck O, Woodward K, Woosley JT, Shaheen NJ.

Am J Gastroenterol. 2015 Mar 17. doi: 10.1038/ajg.2015.57. [Epub ahead of print]

PMID:
25781367
5.

Safety and efficacy of endoscopic spray cryotherapy for Barrett's dysplasia: results of the National Cryospray Registry.

Ghorbani S, Tsai FC, Greenwald BD, Jang S, Dumot JA, McKinley MJ, Shaheen NJ, Habr F, Coyle WJ.

Dis Esophagus. 2015 Feb 24. doi: 10.1111/dote.12330. [Epub ahead of print]

PMID:
25708903
6.

Randomised clinical trial: the 5-HT4 agonist revexepride in patients with gastro-oesophageal reflux disease who have persistent symptoms despite PPI therapy.

Shaheen NJ, Adler J, Dedrie S, Johnson D, Malfertheiner P, Miner P, Meulemans A, Poole L, Tack J, Thielemans L, Troy S, Vakil N, Zerbib F, Ruth M.

Aliment Pharmacol Ther. 2015 Apr;41(7):649-61. doi: 10.1111/apt.13115. Epub 2015 Feb 19.

PMID:
25693609
7.

The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark.

Dellon ES, Erichsen R, Baron JA, Shaheen NJ, Vyberg M, Sorensen HT, Pedersen L.

Aliment Pharmacol Ther. 2015 Apr;41(7):662-70. doi: 10.1111/apt.13129. Epub 2015 Feb 12.

PMID:
25684441
8.

Quality indicators common to all GI endoscopic procedures.

Rizk MK, Sawhney MS, Cohen J, Pike IM, Adler DG, Dominitz JA, Lieb JG 2nd, Lieberman DA, Park WG, Shaheen NJ, Wani S.

Gastrointest Endosc. 2015 Jan;81(1):3-16. doi: 10.1016/j.gie.2014.07.055. Epub 2014 Dec 2. No abstract available.

PMID:
25480102
9.

Quality indicators for EGD.

Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, Laine LA, Lieb JG 2nd, Rizk MK, Sawhney MS, Wani S.

Gastrointest Endosc. 2015 Jan;81(1):17-30. doi: 10.1016/j.gie.2014.07.057. Epub 2014 Dec 2. No abstract available.

PMID:
25480101
10.

Quality indicators for colonoscopy.

Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS.

Gastrointest Endosc. 2015 Jan;81(1):31-53. doi: 10.1016/j.gie.2014.07.058. Epub 2014 Dec 2. No abstract available.

PMID:
25480100
11.

Quality indicators for ERCP.

Adler DG, Lieb JG 2nd, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S.

Gastrointest Endosc. 2015 Jan;81(1):54-66. doi: 10.1016/j.gie.2014.07.056. Epub 2014 Dec 2. No abstract available.

PMID:
25480099
12.

Quality indicators for EUS.

Wani S, Wallace MB, Cohen J, Pike IM, Adler DG, Kochman ML, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Tokar JL.

Gastrointest Endosc. 2015 Jan;81(1):67-80. doi: 10.1016/j.gie.2014.07.054. Epub 2014 Dec 2. No abstract available.

PMID:
25480097
13.

Quality indicators common to all GI endoscopic procedures.

Rizk MK, Sawhney MS, Cohen J, Pike IM, Adler DG, Dominitz JA, Lieb JG 2nd, Lieberman DA, Park WG, Shaheen NJ, Wani S.

Am J Gastroenterol. 2015 Jan;110(1):48-59. doi: 10.1038/ajg.2014.383. Epub 2014 Dec 2. No abstract available.

PMID:
25448874
14.

Quality indicators for colonoscopy.

Rex DK, Schoenfeld PS, Cohen J, Pike IM, Adler DG, Fennerty MB, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Wani S, Weinberg DS.

Am J Gastroenterol. 2015 Jan;110(1):72-90. doi: 10.1038/ajg.2014.385. Epub 2014 Dec 2. No abstract available.

PMID:
25448873
15.

Quality indicators for EGD.

Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, Laine LA, Lieb JG 2nd, Rizk MK, Sawhney MS, Wani S.

Am J Gastroenterol. 2015 Jan;110(1):60-71. doi: 10.1038/ajg.2014.384. Epub 2014 Dec 2. No abstract available.

PMID:
25448872
16.

Quality indicators for EUS.

Wani S, Wallace MB, Cohen J, Pike IM, Adler DG, Kochman ML, Lieb JG 2nd, Park WG, Rizk MK, Sawhney MS, Shaheen NJ, Tokar JL.

Am J Gastroenterol. 2015 Jan;110(1):102-13. doi: 10.1038/ajg.2014.387. Epub 2014 Dec 2. No abstract available.

PMID:
25448871
17.

Quality indicators for ERCP.

Adler DG, Lieb JG 2nd, Cohen J, Pike IM, Park WG, Rizk MK, Sawhney MS, Scheiman JM, Shaheen NJ, Sherman S, Wani S.

Am J Gastroenterol. 2015 Jan;110(1):91-101. doi: 10.1038/ajg.2014.386. Epub 2014 Dec 2. No abstract available.

PMID:
25448869
18.

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus.

Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Castro Giner F, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Moayyedi P, Watson P, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J.

Gastroenterology. 2015 Feb;148(2):367-78. doi: 10.1053/j.gastro.2014.10.041. Epub 2014 Nov 5.

19.

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma.

Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, Galipeau PC, Shaheen NJ, Hardie LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL.

Carcinogenesis. 2014 Dec;35(12):2740-7. doi: 10.1093/carcin/bgu207. Epub 2014 Oct 3.

PMID:
25280564
20.

Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.

Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chanock SJ, Chow WH, Casson AG, Levine DM, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC.

J Natl Cancer Inst. 2014 Sep 30;106(11). pii: dju252. doi: 10.1093/jnci/dju252. Print 2014 Nov.

PMID:
25269698
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk